Skip to content

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07478276
Enrollment
84
Registered
2026-03-17
Start date
2028-01-01
Completion date
2028-12-01
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

rehabilitation, prehabilitation, physical exercise, respiratory physiotherapy, multidisciplinary program, oncological treatment, adherence to treatment

Brief summary

Lung cancer remains a leading cause of morbidity and mortality, and resective surgery is the treatment of choice in operable stages. However, a significant proportion of patients present with functional impairment prior to surgery and develop postoperative complications, especially respiratory ones. Prehabilitation has become established as a strategy capable of optimizing physical condition before surgery, while early rehabilitation contributes to accelerating recovery after discharge. Nevertheless, its routine implementation is limited by logistical barriers, short waiting times, and difficulties in accessing in-person care. The PulmoSalud project proposes a multimodal program, consisting of 8 weeks of prehabilitation (strength and endurance exercises, and respiratory physiotherapy) and 4 weeks of early home-based rehabilitation, supported by a specific digital application, in order to facilitate continuity of care without the need for additional travel. The content includes progressive strength training, structured breathing exercises (including inspiratory muscle training), educational guidelines, and digital recording of activity and symptoms. Patients will receive initial in-person training to ensure the correct execution of the exercises, and will subsequently continue independently with remote supervision. A controlled study will be conducted comparing this program with the center's standard care. Functional variables (aerobic capacity, muscle strength), respiratory parameters, postoperative complications, quality of life, self-efficacy, and healthcare resource utilization will be evaluated. Measurements will be taken at three time points: baseline (T0), immediate pre-surgical (T1), and one month post-surgery (T2). PulmoSalud aims to improve preoperative preparation, accelerate post-surgical recovery, and reduce the burden on healthcare services by safely integrating a home-based intervention supported by digital technology.

Interventions

OTHERIndividualized pre-operative physical exercise

1. Warm-up and mobility (8-10 minutes): Overall mobility of the spine, shoulder girdle, and hips; light walking or cycling; progressive muscle activation. 2. Aerobic training (12-20 minutes): Options include walking, treadmill, or stationary cycling. Moderate intervals (light HIIT). 3. Strength training (15-25 minutes): Performed with resistance bands, light dumbbells, and bodyweight exercises, with special emphasis on the lower limbs and relevant scapular muscles following thoracic surgery: assisted squats or sit-to-stand exercises; low and high banded rows; chest presses with bands or light dumbbells; hip raises; lateral marches with bands; scapular work (retraction, Y-T-W). 4. Cool-down (5-8 minutes): Thoracic and scapular mobility exercises; controlled breathing (coordinated with respiratory physiotherapy). Independent home session (1 time/week): Performed with the support of the PulmoSalud application.

OTHERPost-operative rehabilitation physical exercise

1. Initial recovery: Light walking 10-15 min/day, RPE 2-3, very basic strength exercises (1 set): Supported sit-to-stand, lateral walking, gentle scapular retraction, strengthening of thoracic mobility, and breathing exercises from the clinical protocol. 2. Progressive functional recovery: Walking 15-25 min/day, RPE 4-5, introduction of light intervals (30 seconds fast / 90 seconds slow), strength circuit (2 sets): Assisted squat, banded row, hip thrust, add scapular work as tolerated.

OTHERRespiratory physiotherapy Prehabilitation

Re-education and control of the respiratory pattern, Lung expansion exercises (EDIC) and segmental ventilation, Basic secretion management techniques, Scar protection education and cough management (videos + daily practice), Thoracic mobility and gentle non-impact physical activity, Inspiratory muscle training (IMT), Mobile application (App) for support during postoperative rehabilitation.

DEVICESupporting mobile application (App)

The app will be used as an educational tool and for self-monitoring by the patient, allowing them to record basic parameters daily, such as dyspnea (Borg scale), pain, sleep quality, and adherence to exercise sessions, IMT (Inspiratory Muscle Training), and breathing exercises. The app includes demonstration videos of breathing techniques, education on scar protection, and preoperative preparation materials, as well as scheduled notifications for IMT, chest expansion exercises, and physical activity, in addition to brief self-assessment quizzes. The app's use will be exclusively educational and to support self-management, without remote monitoring or transmission of clinical data to the healthcare team.

OTHERHome-based respiratory physiotherapy

Re-education and control of the breathing pattern, Lung expansion exercises and directed ventilation, Safe bronchial hygiene techniques, Scar protective education and effective pain-free coughing strategies, Inspiratory muscle training, Whole body ventilatory training.

Sponsors

FranciscoVeraSerrano
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years. 2. Histological or cytological diagnosis of lung cancer (resectable stage according to the multidisciplinary team). 3. Patients scheduled for lung surgery with curative intent (lobectomy, segmentectomy, pneumonectomy, etc.). 4. Ability to understand and sign informed consent. 5. Clinical condition that allows participation in a supervised exercise program, according to medical evaluation, with an ECOG performance status of 0-2 (Eastern Cooperative Oncology Group Performance Status). 6. Availability to perform the scheduled measurements and follow-ups (preoperative and postoperative). 7. Ability to use the mobile application or have family support to do so.

Exclusion criteria

1\. Absolute medical contraindications to supervised physical exercise, such as unstable angina, recent decompensated heart failure, uncontrolled arrhythmias, or acute cardiovascular events within the last 3 months. 2\. Very advanced chronic lung disease that prevents participation in the program (e.g., severe COPD with FEV1 \< 30% predicted, as determined by the clinical team). 3\. Distant metastases or metastatic cancer that contraindicate surgery with curative intent. 4\. Planned palliative surgery or life expectancy \< 3 months. 5\. Home oxygen therapy with severe, uncorrectable hypoxemia, as determined by clinical judgment. 6\. Moderate-to-severe cognitive, neurological, or psychiatric impairment that prevents understanding of the study or proper use of the mobile application. 7. An insurmountable language barrier that prevents understanding the study information or using the mobile application. 8\. Pregnancy. 9\. Participation in another interventional clinical trial that may interfere with the study objectives or its primary outcome. 10\. Any other condition that, in the opinion of the research team, compromises the participant's safety or adherence to the protocol. Withdrawal Criteria 1. Withdrawal of consent. 2. Adverse events that contraindicate continued exercise (clinical decision). 3. Failure to complete more than 30% of planned sessions (for per-protocol analysis; continue in ITT).

Design outcomes

Primary

MeasureTime frame
FEV1 (L and % predicted)From the start of treatment until its completion at 12 weeks.
FVC (L and % predicted)From the start of treatment until its completion at 12 weeks.
FEV1/FVC:From the start of treatment until its completion at 12 weeks.
6 minute walk test (6MWT): continuous quantitative variable (meters).From the start of treatment until its completion at 12 weeks
30-Second Sit-to-Stand TestFrom the start of treatment until its completion at 12 weeks

Secondary

MeasureTime frame
Hand grip dynamometryFrom the start of treatment until its completion at 12 weeks.
Estimated maximum strength 1RMFrom the start of treatment until its completion at 12 weeks
Bruce's ramp testFrom the start of treatment until its completion at 12 weeks
Submaximal heart rate reached (80%, heart rate monitor)From the start of treatment until its completion at 12 weeks
FAACT-A/CS Questionnaire (anorexia-cachexia)From the start of treatment until its completion at 12 weeks
diet qualityFrom the start of treatment until its completion at 12 weeks
International Physical Activity Questionnaire (IPAQ)From the start of treatment until its completion at 12 weeks
Subjective perception of effort (RPE, scale 0-10)From the start of treatment until its completion at 12 weeks
Godin questionnaireFrom the start of treatment until its completion at 12 weeks
maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)From the start of treatment until its completion at 12 weeks.
Peak Cough Flow (PCF)From the start of treatment until its completion at 12 weeks.
mMRC scaleFrom the start of treatment until its completion at 12 weeks.
modified Borg scaleFrom the start of treatment until its completion at 12 weeks.

Contacts

CONTACTMaría Jesús Viñolo Gil, Physiotherapy Doctor
mariajesus.vinolo@gm.uca.es609072670

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026